Clinical trial
A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease
NCT00317369 · Otsuka Pharmaceutical Co., Ltd., Industry · Terminated
Key facts
| NCT number | NCT00317369 |
|---|---|
| Title | A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease |
| Official title | A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease |
| Lead sponsor | Otsuka Pharmaceutical Co., Ltd., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Crohn Disease |
| Intervention type | Drug |
| Interventions | OPC-6535(Tetomilast) |
| Enrollment | 29 |
| Start date | May 1, 2006 |
| Primary completion | Jul 11, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Apr 24, 2006 |
| Last update posted | Feb 15, 2021 |
| Countries | Japan |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: